Navigation Links
Optimer Pharmaceuticals to Present at March 2011 Investor Conferences
Date:3/1/2011

SAN DIEGO, March 1, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced that the Company will present at the following investor conferences:

  • Citi 2011 Global Health Care Conference on Thursday, March 3, 2011 at 10:00 a.m. Eastern Time at the Hilton New York Hotel in New York City.
  • Cowen and Company 31st Annual Health Care Conference on Monday, March 7, 2011 at 4:45 p.m. Eastern Time at The Boston Marriott Copley Place in Boston.

  • (Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

    Live audio webcasts of these presentations will be accessible on the Investors page of the Company's website at www.optimerpharma.com.  Replays of these presentations will be available at the same location for 30 days following the meeting.

    About Optimer PharmaceuticalsOptimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing hospital specialty products to treat serious infections and address unmet medical needs. Optimer has two anti-infective product candidates in development, fidaxomicin and Pruvel™ (prulifloxacin). Fidaxomicin is a narrow spectrum antibiotic being developed for the treatment of Clostridium difficile infection (CDI). The FDA granted the Company's request for six-month Priority Review of fidaxomicin, and has assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 30, 2011. The Company also filed a MAA with the European Medicines Agency (EMA) for fidaxomicin. Pruvel™ is a prodrug in the fluoroquinolone class of antibiotics being developed as a treatment for infectious diarrhea. Additional information can be found at http://www.optimerpharma.com. ContactsOptimer Pharma
    '/>"/>

    SOURCE Optimer Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock
    2. Optimer Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
    3. Optimer Pharmaceuticals and Astellas Announce Collaboration to Commercialize Fidaxomicin for Clostridium difficile infection (CDI) in Europe and Certain Other Countries in Middle East, Africa and CIS
    4. Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI)
    5. Optimer Pharmaceuticals Appoints Hank McKinnell to Its Board of Directors
    6. Optimer Pharmaceuticals Announces Key Additions to Management Team
    7. Optimer Pharmaceuticals Obtains Additional Fidaxomicin Patent
    8. Optimer Pharmaceuticals Receives Orphan Drug Designation for Fidaxomicin for the Treatment of Pediatric Clostridium difficile Infection
    9. Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations
    10. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
    11. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... Kan. , Dec. 18, 2014   ... ), a biopharmaceutical company focused on the licensing, ... animals, today announced positive results from its pivotal ... drug for treating pain in dogs with osteoarthritis. ... in pain assessment scores that were statistically significant ...
    (Date:12/17/2014)... -- Los beneficios y ganancias están por ... gasto en investigación y desarrollo   En ... septiembre de 2014) ZEISS aumentó sus ingresos en un ... anterior: 4.190 millones de euros) a pesar de los ... un 14 por ciento, a 360 millones de euros. ...
    (Date:12/17/2014)... 2014 With advancements in neurological and ... is seeing new growth, according to Kalorama Information. ... for the majority of market volume, newer 3T ... which are creating opportunities for more sophisticated applications. The ... at a rate of 4%, with world market ...
    Breaking Medicine Technology:Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5ZEISS confirma su posición en un entorno difícil 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3
    (Date:12/20/2014)... 2014 Developers of FCPX ... new plugin for Final Cut Pro X entitled TranSlice ... 5 allows users to create hand drawn text animations ... Austin, CEO of Pixel Film Studios. “TranSlice Volume 5 ... maintaining an easy to use interface.” , TranSlice Volume ...
    (Date:12/20/2014)... 20, 2014 Today, Balfleet.com, one of ... Christmas Sale, offering 50%-70% off on its Mother ... , The mother of the bride dresses from Balfleet.com ... is 24/7 accessible and takes pride in providing high ... “We are offering great discounts on our mother of ...
    (Date:12/19/2014)... Sub Zero Ice Cream is partnering up with the ... 28th from 2pm-6pm at the Expo Center on the northeast ... , Inquiries regarding time slots and signing up, email todd.subzeroicecream(at)gmail(dot)com. ... process, Sub Zero Ice Cream & Yogurt will be offering ... About Sub Zero Ice Cream & Yogurt , Sub ...
    (Date:12/19/2014)... CA (PRWEB) December 19, 2014 SuperCloset ... 5x5 SuperClone Rooms. SuperCloset continues to offer indoor growers ... Pair one of the new SuperClone Rooms with the ... perpetual, and turnkey indoor hydroponic grow room setup. , ... the world, SuperCloset’s SuperPonic SuperCloner 50 . ...
    (Date:12/19/2014)... 2014 The Medspa at Hendrick in ... from respected cosmetic brand Juvéderm. Voluma XC treats volume ... The Medspa at Hendrick is pleased to be able ... technology to its clients. , Voluma is the first ... to treat the mid-face and cheek area. This non-invasive ...
    Breaking Medicine News(10 mins):Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2Health News:Balfleet.com is Offering 50%-70% Off of its Mother of the Bride Dresses 2Health News:Shark Tank’s Sub Zero Ice Cream Sponsors Blood Drive 2Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2
    ... either way because of salty sauces , , MONDAY, Oct. 20 ... that are staples of the Western diet account for about ... new report suggests. , Meanwhile, a diet rich in fruits ... risk of heart attack, according to the study, published in ...
    ... heart attacks , , MONDAY, Oct. 20 (HealthDay News) -- A ... reduce the risks of surgery. , The death rate for ... higher in the 30 days after an operation than for ... according to a report in the October issue of the ...
    ... risk of chronic diseases and,can help reduce health care ... Oct. 20 Small steps can lead to big,health ... campaign,launched today. As families stretch to make ends meet ... American Medical Association,s campaign,can help people live a healthy ...
    ... 20 Lincare Holdings,Inc. (Nasdaq: LNCR ), a ... to patients in the home, today announced,financial results for ... For the quarter ended September 30, 2008, revenues ... the third quarter of 2007. The,Company estimates that the ...
    ... 20 Insulet Corporation,(Nasdaq: PODD ), the leader ... today announced the appointment of Sally W.,Crawford to its ... the former chief operating officer of Healthsource Inc., a ... Partners, a venture,capital firm in life sciences, on Insulet,s ...
    ... play a major role, study suggests , , MONDAY, Oct. ... likely to die in U.S. emergency rooms after a ... uninsured ER patients are more likely to die compared ... October issue of the Archives of Surgery . ...
    Cached Medicine News:Health News:Western Diet Boosts Global Heart Attack Risk 30% 2Health News:Questions Continue About Using Beta Blockers Before Surgery 2Health News:Questions Continue About Using Beta Blockers Before Surgery 3Health News:AMA Aims to Help Americans Get Healthier One Step at a Time 2Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results 2Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results 3Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results 4Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results 5Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results 6Health News:Sally W. Crawford Joins Insulet's Board of Directors 2Health News:Sally W. Crawford Joins Insulet's Board of Directors 3Health News:Sally W. Crawford Joins Insulet's Board of Directors 4Health News:Minorities More Likely to Die in ER 2Health News:Minorities More Likely to Die in ER 3
    PremierEdge Stab Knives - 30....
    PremierEdge™ Stab Knives - 15°....
    Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
    Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
    Medicine Products: